arrow
A

Ane Mínguez-Olaondo

hospital universitario donostia-osakidetza and biogipuzkoa health institute
H指数:10
被引数:501

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study

评估抗CGRP单克隆抗体在偏头痛和自身免疫性疾病患者中的有效性与安全性:IMMUNO-CGRP研究

IF0
2026-04-010
OAAI
Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

阿托格匹兰坦在抗CGRP单克隆抗体治疗失败的偏头痛患者中的应用:一项关于疗效、安全性、持续性和应答预测因子的多中心真实世界研究

2025-11-280
OAAI
Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real-life multicenter study

Galcanezumab预防≥65岁患者偏头痛的有效性与耐受性:一项真实世界多中心研究

IF0
2025-10-140
OAAI
Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology's Headache Study Group

颅内压紊乱的诊断和治疗:西班牙神经病学学会头痛研究组的共识声明

2025-01-012
OAAI
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
2023-11-223
OAAI
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
2023-06-0220
OAAI
From transformation to chronification of migraine: pathophysiological and clinical aspects

从偏头痛的转变到慢性: 病理生理和临床方面

2020-04-2976
OAAI